Adverse Drug Reactions due to Longer oral M/XDR-TB Regimen
Adverse Drug Reactions due to Longer oral M/XDR-TB Regimen
Use of Longer Oral M/XDR-TB Regimen in Severe Forms of Extrapulmonary TB and TB Meningitis
Use of Longer Oral M/XDR-TB Regimen in Severe Forms of Extrapulmonary TB and TB Meningitis
Pre-treatment Evaluation [PTE] in Longer Oral M/XDR-TB Regimen
Pre-treatment Evaluation [PTE] in Longer Oral M/XDR-TB Regimen
Use of M/XDR-TB Regimen in People Living with HIV [PLHIV]
Use of M/XDR-TB Regimen in People Living with HIV [PLHIV]
Clinical Monitoring of DR-TB Patients
- Read more about Clinical Monitoring of DR-TB Patients
- Log in to post comments
Clinical Monitoring of DR-TB Patients
Management of Drug-resistant TB
- Read more about Management of Drug-resistant TB
- Log in to post comments
Describe Management of Drug-resistant TB.
Rapid Molecular Drug-resistance Testing
- Read more about Rapid Molecular Drug-resistance Testing
- Log in to post comments
Rapid Molecular Drug-resistance Testing
DR-TB Service Referral Linkages Scenario: DR-TB Patient Referred for Treatment from the Private Sector with Treatment Initiated in the Private Sector
DR-TB Service Referral Linkages Scenario 5: DR-TB Patient Referred for Treatment from the Private Sector with Treatment Initiated in the Private Sector
DR-TB Service Referral Linkages Scenario: DR-TB Patient Referred for Treatment from the Private Sector with Bacteriological Confirmation in the Private Sector
DR-TB Service Referral Linkages Scenario 3: DR-TB Patient Referred for Treatment from the Private Sector with Bacteriological Confirmation in the Private Sector
DR-TB Services Referral Linkage Scenario: Patient Notified from the Private Sector
DR-TB Services Referral Linkage Scenario 1: Patient Notified from the Private Sector